Home » Japan Green Lights Medinol Stent Trial
Japan Green Lights Medinol Stent Trial
November 9, 2016
Japanese regulators approved a clinical trial of Medinol’s Elunir drug-eluting stent.
The thin-strut, ridaforolimus-eluting Elunir stent (previously known as Bionir) has an elastomeric coating that’s designed to be more flexible than prior-generation polymer coatings.
Japan’s Pharmaceutical & Medical Devices Agency granted clinical trial notification for the single-arm, 100-patient JNIR study to confirm Elunir/Bionir’s safety and efficacy in the Japanese clinical environment with a primary endpoint of target lesion failure. — Cynthia Jessup
Upcoming Events
-
21Oct